Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,200.00    3.00 (0.25%)
Bid:
1,202.00
Ask:
1,205.00
Spread: 3.00 (0.25%)
Market Cap: £834.51m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
31st Mar 201711:55 amRNSDirector/PDMR Dealing
31st Mar 20177:00 amRNSInterim Results
15th Mar 20171:39 pmRNSExercise of Options & TVR - Replacement
14th Mar 20175:29 pmRNSExercise of Options & TVR
13th Mar 20174:07 pmRNSHolding(s) in Company
10th Mar 20172:11 pmRNSHolding(s) in Company
8th Mar 20173:31 pmRNSHolding(s) in Company
3rd Mar 20172:37 pmRNSHolding(s) in Company
28th Feb 201710:30 amRNSPurchase of Shares by Employee Benefit Trust
27th Feb 20174:07 pmRNSExercise of Options & TVR
22nd Feb 20173:13 pmRNSHolding(s) in Company
6th Feb 20175:25 pmRNSExercise of Options & Total Voting Rights
27th Jan 201711:27 amRNSExercise of Options, Director/PCA Dealing & TVR
9th Jan 20179:01 amRNSExercise of Options and Total Voting Rights
19th Dec 20164:48 pmRNSHolding(s) in Company
19th Dec 201612:27 pmRNSHolding(s) in Company
19th Dec 201612:15 pmRNSBlock Admission
14th Dec 20161:01 pmRNSResult of Successful £30.2 million Placing & TVR
13th Dec 201610:32 amRNSClose of Accelerated Bookbuild
13th Dec 20167:00 amRNSProposed Accelerated Bookbuild
6th Dec 20161:07 pmRNSHolding(s) in Company
1st Dec 20165:02 pmRNSHolding(s) in Company
29th Nov 201610:05 amRNSHolding(s) in Company
24th Nov 201611:46 amRNSResult of AGM
24th Nov 20167:00 amRNSAGM Statement
15th Nov 20164:36 pmRNSDirector/PDMR and PCA Shareholding
3rd Nov 20169:49 amRNSPosting of Annual Report and Notice of AGM
31st Oct 201610:23 amRNSDirector/PDMR Shareholding
27th Oct 20164:14 pmRNSHolding(s) in Company
26th Oct 20168:50 amRNSExercise of Options, Directors' Dealing and TVR
25th Oct 20163:30 pmRNSDirector/PDMR Shareholding
25th Oct 20162:41 pmRNSHolding(s) in Company
14th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 201611:40 amRNSExercise of Options and Total Voting Rights
11th Oct 20164:37 pmRNSHolding(s) in Company
6th Oct 20163:10 pmRNSHolding(s) in Company
5th Oct 20164:26 pmRNSHolding(s) in Company
4th Oct 20163:47 pmRNSHolding(s) in Company
28th Sep 201612:56 pmRNSHolding(s) in Company
23rd Sep 20167:00 amRNSPreliminary Results
22nd Sep 20161:31 pmRNSHolding(s) in Company
16th Sep 20162:43 pmRNSHolding(s) in Company
14th Sep 20165:31 pmRNSHolding(s) in Company
14th Sep 20165:00 pmRNSHolding(s) in Company
12th Sep 20163:52 pmRNSHolding(s) in Company
8th Sep 20165:21 pmRNSHolding(s) in Company
5th Sep 201611:35 amRNSHolding(s) in Company
26th Aug 20165:15 pmRNSHolding(s) in Company
12th Aug 201611:50 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.